Atara Biotherapeutics, Inc. (ATRA) vs PMV Pharmaceuticals, Inc. (PMVP)

A side-by-side comparison of Atara Biotherapeutics, Inc. and PMV Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ATRA vs PMVP

growth of $100 · dividends reinvested · last 6y
ATRA -97.1% (-44.6%/yr)PMVP -95.3% (-39.8%/yr)PMVP compounded faster over this window
050100150Start $100202120222023202420252026$3$5
ATRA PMVP

ATRA vs PMVP: by the numbers

  • •PMVP is the larger company ($90M vs $84M market cap).
  • •Both run net losses; PMVP's is the smaller (0.00% vs -269.42% net margin).

Metrics side by side

Valuation

MetricATRAPMVP
P/S ratio13.50N/A
P/B ratioN/A1.26

Profitability

MetricATRAPMVP
Gross margin82.44%0.00%
Operating margin29.69%0.00%
Net margin-269.42%0.00%
ROEN/A-105.20%
ROIC-100.35%-111.42%

Growth (annualized)

MetricATRAPMVP
Revenue CAGR (5Y)56.10%N/A
Total return CAGR (5Y)-53.60%-43.17%

Frequently asked

How have ATRA and PMVP total returns compared?
Over the past 5 years, ATRA delivered -53.60% and PMVP delivered -43.17% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.